Arixtra injection. FDA approves synthetic anticlotting drug.
D017277:Drug Approval; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000077425:Fondaparinux; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use*; D014481:United States
D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux